SG Americas Securities’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-38,056
Closed -$25K 3092
2022
Q3
$25K Buy
38,056
+122
+0.3% +$172 ﹤0.01% 3082
2022
Q2
$70K Sell
37,934
-6,120
-14% -$13.2K ﹤0.01% 3213
2022
Q1
$142K Buy
+44,054
New +$149K ﹤0.01% 2613
2021
Q1
Sell
-35,743
Closed -$433K 3307
2020
Q4
$433K Buy
35,743
+24,197
+210% +$334K ﹤0.01% 2084
2020
Q3
$188K Buy
11,546
+1,543
+15% +$25.3K ﹤0.01% 2184
2020
Q2
$150K Buy
+10,003
New +$135K ﹤0.01% 3100
2017
Q1
Sell
-18,071
Closed -$92K 3293
2016
Q4
$92K Buy
+18,071
New +$108K ﹤0.01% 2885
2014
Q2
Sell
-19,521
Closed -$205K 2539
2014
Q1
$205K Buy
+19,521
New +$215K ﹤0.01% 1920

Other funds holding CGEN

SG Americas Securities's CGEN Position: Q4 2022 in Review

SG Americas Securities sold out of Compugen (CGEN) in Q4 2022, closing a stake of 38,056 shares — an estimated $25K sold.

SG Americas Securities first reported a position in CGEN in Q1 2014 and held it in 8 quarters. The position peaked at $433K in Q4 2020. 74 funds tracked by Wall St. Rank hold CGEN as of Q4 2022.

  • SG Americas Securities reported no remaining Compugen position as of Q4 2022 after selling out during the quarter.
  • SG Americas Securities sold 38,056 Compugen shares in Q4 2022, an estimated $25K.
  • SG Americas Securities first reported a position in Compugen in Q1 2014 and held it in 8 quarters.
  • SG Americas Securities's Compugen position peaked at $433K in Q4 2020.
  • 74 funds tracked by Wall St. Rank held Compugen as of Q4 2022.

Based on SG Americas Securities's 13F filing for Q4 2022, filed 2 Feb 2023.